Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The renal sodium transport system is a complex network of proteins and physiological pathways responsible for the precise regulation of sodium reabsorption along the nephron. This system ensures that over 99% of the sodium filtered by the glomerulus is returned to the systemic circulation, a process essential for maintaining extracellular fluid volume, blood pressure, and acid-base homeostasis [3, 8]. Key molecular components include the sodium-glucose cotransporter 2 (SGLT2) in the proximal tubule, the sodium-potassium-chloride cotransporter 2 (NKCC2) in the thick ascending limb, the sodium-chloride cotransporter (NCC) in the distal convoluted tubule, and the epithelial sodium channel (ENaC) in the collecting duct [1, 10]. These transporters are primarily driven by the electrochemical gradient generated by the basolateral sodium-potassium-exchanging ATPase (Na+/K+-ATPase) [7, 14]. Dysfunction of these transport pathways, often due to genetic mutations or hormonal imbalances, leads to significant clinical conditions such as hypertension, heart failure, and rare tubulopathies like Bartter, Gitelman, and Liddle syndromes [3, 15]. Pharmacological targeting of these pathways is a fundamental strategy in medicine, utilizing diuretics and SGLT2 inhibitors to manage fluid overload and metabolic disorders [13, 15]. While highly effective, these therapies require careful monitoring due to risks of severe electrolyte disturbances, dehydration, and potential impacts on glomerular filtration rate [2, 12].
Inhibition of sodium reabsorption at specific segments of the nephron—including the proximal tubule, thick ascending limb, distal convoluted tubule, and collecting duct—to promote natriuresis and diuresis, thereby reducing extracellular fluid volume and blood pressure [3, 10, 13].
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renal sodium transport system.